Status:
COMPLETED
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Attention Deficit Disorder With Hyperactivity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study will determine the effectiveness of group cognitive-behavioral therapy as compared to a problem-solving social support group in treating problems of time management, organization, and plann...
Detailed Description
ADHD is a chronic neurobiological condition that affects people of all ages, genders, and races. Symptoms of ADHD may include, but are not limited to, the following: poor attention span; physical rest...
Eligibility Criteria
Inclusion
- Suspected of having or have been diagnosed with ADHD
- May potentially benefit from the ADHD group treatment
Exclusion
- Any overt cognitive disability (e.g., Alzheimer's disease, mental retardation)
- Deemed not to potentially benefit from the proposed ADHD group treatment
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT00278473
Start Date
May 1 2005
End Date
October 1 2008
Last Update
April 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029